- Intestinal Organoids – An important advancement in the way we study intestinal and adult stem cell biologyPosted 1 week ago
- 10 Biologics on Best Selling Drugs List for 2014Posted 2 weeks ago
- Cell Therapy: Are we there yet?Posted 3 weeks ago
- Minimize the Impact of Stress on Pluripotent Stem Cell Health – A DiscussionPosted 3 weeks ago
- Materials and Assay Systems Used for 3D Cell CulturePosted 4 weeks ago
- 2014 FDA New Drug Approvals – 11 Biologics Receive ApprovalPosted 1 month ago
- Application of the Roche Cedex Bio Analyzer in the Culture of Human Pancreatic Islets and Adult Human Mesenchymal Stem CellsPosted 1 month ago
- Intestinal Organoid Culture: a Convenient and Physiologically Relevant Model for Intestinal and Stem Cell ResearchPosted 2 months ago
- The Evolution of Vaccine Manufacturing – Past, Current, and Future TrendsPosted 2 months ago
- Reprogramming Blood Cells: How to Decrease Variability in Your WorkflowPosted 2 months ago
The Dish’s Weekly News Wrap Up – August 31, 2012
This week’s headlines include, Appeals Court rules on embryonic stem cell research, Top 25 Biotechs, innovative stem cell therapy developments, a new influenza vaccine study and Roche’s breast cancer drug promises longer survival. Cell Culture Events: Attend...
- Posted August 31, 2012
Defined Supplements – The Role of Recombinant Proteins in Biopharmaceutical Manufacturing
Defined supplements that improve growth, productivity and consistency are highly attractive for cell culture optimization projects. And, recombinant proteins are increasingly being used as defined supplements in biopharmaceutical, vaccine and stem cell manufacturing. The use of recombinant...
- Posted August 28, 2012
The Dish’s Weekly News Wrap Up – August 24, 2012
This week’s headlines include, innovative stem cell therapy trials, another vaccination success story, new breast cancer drug report, Myriad wins gene patent ruling, and the advantages of targeting rare diseases. “Chicken Pox Cases Fall 80% Over Decade:...
- Posted August 24, 2012
Venture Capital Investment in the Life Science Sector is Down for 2012 – Is There a Light at the End of the Tunnel?
Venture capital investment in the life science sector is down both in total number of venture dollars and number of deals according to the Dollar Drought Moneytree Life Sciences Report, published this month by Price Waterhouse Cooper....
- Posted August 23, 2012
The Dish’s Weekly News Wrap Up – August 17, 2012
This week’s headlines include, influenza and ebola vaccine developments, investment updates, the latest business deals, researchers get one step closer to regenerating the human heart and a new study shows promising results for use of an existing...
- Posted August 17, 2012